Tag Archives: bioscience

ICYMI: Gov. Tom Ridge, Tara O’Toole on Investing in Bioscience to Protect Against Bioterror

synthetic biology

Writing in the Pittsburgh Post-Gazette last week, Governor Tom Ridge and Tara O’Toole remind us that dangerous diseases are emerging more and more frequently, and that investment in bioscience is critical to fight these drug-resistant infections. When we cannot or fail to halt this spread, they create epidemics. This summer, the world is struggling to contain the spread of the Zika virus. Last fall, it was Ebola. Before that, it was MERS, SARS, avian flu. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Governor of Iowa Kicks Off #BIO2016 Biofuels and Renewable Chemicals Track


On Monday, June 7, 2016, The Honorable Terry Branstad, Governor of Iowa, provided welcoming remarks to the #BIO2016 attendees participating in the Biofuels and Renewable Chemicals Track Sessions.  Governor Branstad is not only the longest serving governor in American history but he was Iowa’s longest-serving governor, from 1983 to 1999. As the state’s chief executive, he endured some of Iowa’s worst economic turmoil, during the farm crisis of the ‘80s, while helping lead the state’s resurgence to a booming economy Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Biotech is Growing in Colorado


Last month I posted a link to an interview featuring Colorado BioScience Association‘s (CBSA) Executive Vice President, April Giles. The interview briefly touched on some of the innovation happening in the state. Though, I was curious to know a bit more about CBSA’s effort to grow and support the industry. So, I was pleased when April kindly agreed to participate in a Q&A. Her answers below offer insight into critical elements of bioscience economic development Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , ,

BioSpectrum Asia Survey Shows Promising Results for the Biosciences Industry


BioSpectrum Asia recently completed a survey of close to 500 bioscience companies listed on different stock exchanges in both the Asia Pacific region (APAC) and in American stock exchanges, with total revenue of $139 billion (year end 2011) and market capitalization of $200 billion. The survey says of the top 20 companies in the region, comprising mostly of pharmaceutical, biotechnology and medical technology companies and focusing on R&D, manufacturing and marketing of life sciences products, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Georgia Bio Recognizes Two State Legislators with Annual Award

England and Staton

While the economic climate has been difficult for bioscience companies, it has also had a significant impact on state budgets, causing many states to cut programs and reassess economic priorities. That said, the bioscience industry has remained a valuable growth area, both in the United States and abroad. Therefore, it’s not surprising that local and state government leaders continue to support economic development initiatives that encourage the growth of this industry. This week, Georgia Bio Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,